Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q01114

Entry ID Method Resolution Chain Position Source
8DDD NMR - B 268-298 PDB
AF-Q01114-F1 Predicted AlphaFoldDB

49 variants for Q01114

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3389153846 2 A>* No EVA
rs3389146678 2 A>V No EVA
rs243382053 8 A>V No EVA
rs232950109 17 A>T No EVA
rs260186884 29 W>C No EVA
rs254366318 38 V>I No EVA
rs3401818634 50 A>D No EVA
rs251913050 52 A>T No EVA
rs48507356 68 S>L No EVA
rs3389086833 75 E>V No EVA
rs214433136 88 T>A No EVA
rs47492407 91 K>N No EVA
rs238816843 95 T>I No EVA
rs3389120627 96 F>I No EVA
rs3389146666 120 T>R No EVA
rs3389148068 123 R>C No EVA
rs231914282 156 V>I No EVA
rs3389149450 167 I>T No EVA
rs50540382 179 S>N No EVA
rs3389144164 185 K>M No EVA
rs3389146668 189 E>* No EVA
rs3389149405 194 R>G No EVA
rs224243234 200 V>F No EVA
rs3389145403 201 G>R No EVA
rs261022887 210 V>I No EVA
rs249160717 217 I>V No EVA
rs108334533 227 T>S No EVA
rs46823302 230 S>R No EVA
rs3402303052 236 E>Q No EVA
rs3389135656 239 Y>F No EVA
rs3389140561 247 W>L No EVA
rs49750132 259 R>T No EVA
rs3389120611 268 Q>K No EVA
rs240904033 276 V>I No EVA
rs3411452391 277 V>M No EVA
rs254063050 289 L>I No EVA
rs3389086797 292 K>T No EVA
rs29461035 297 L>V No EVA
rs262257140 305 I>T No EVA
rs265162327 325 S>T No EVA
rs246861519 330 R>H No EVA
rs3389157049 351 S>N No EVA
rs226922170 356 V>I No EVA
rs3389140619 383 G>E No EVA
rs229369086 384 L>P No EVA
rs260557177 393 A>T No EVA
rs241037623 450 E>Q No EVA
rs3389120688 464 V>M No EVA
rs3402116826 466 S>R No EVA

No associated diseases with Q01114

2 regional properties for Q01114

Type Name Position InterPro Accession
conserved_site Short hematopoietin receptor, family 1, conserved site 212 - 253 IPR003531
domain Fibronectin type III 147 - 256 IPR003961

Functions

Description
EC Number
Subcellular Localization
  • Cell membrane; Single-pass type I membrane protein
  • Secreted
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

5 GO annotations of cellular component

Name Definition
cell surface The external part of the cell wall and/or plasma membrane.
external side of plasma membrane The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

3 GO annotations of molecular function

Name Definition
cytokine receptor activity Combining with a cytokine and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.
interleukin-9 binding Binding to interleukin-9.
interleukin-9 receptor activity Combining with interleukin-9 and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity.

7 GO annotations of biological process

Name Definition
B cell differentiation The process in which a precursor cell type acquires the specialized features of a B cell. A B cell is a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
B cell proliferation The expansion of a B cell population by cell division. Follows B cell activation.
cytokine-mediated signaling pathway The series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
immunoglobulin mediated immune response An immune response mediated by immunoglobulins, whether cell-bound or in solution.
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway.
positive regulation of cell growth Any process that activates or increases the frequency, rate, extent or direction of cell growth.
regulation of peptidyl-tyrosine phosphorylation Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P14753 Epor Erythropoietin receptor Mus musculus (Mouse) PR
Q08351 Mpl Thrombopoietin receptor Mus musculus (Mouse) PR
P26954 Csf2rb2 Interleukin-3 receptor class 2 subunit beta Mus musculus (Mouse) PR
P26955 Csf2rb Cytokine receptor common subunit beta Mus musculus (Mouse) PR
10 20 30 40 50 60
MALGRCIAEG WTLERVAVKQ VSWFLIYSWV CSGVCRGVSV PEQGGGGQKA GAFTCLSNSI
70 80 90 100 110 120
YRIDCHWSAP ELGQESRAWL LFTSNQVTEI KHKCTFWDSM CTLVLPKEEV FLPFDNFTIT
130 140 150 160 170 180
LHRCIMGQEQ VSLVDSQYLP RRHIKLDPPS DLQSNVSSGR CVLTWGINLA LEPLITSLSY
190 200 210 220 230 240
ELAFKRQEEA WEARHKDRIV GVTWLILEAV ELNPGSIYEA RLRVQMTLES YEDKTEGEYY
250 260 270 280 290 300
KSHWSEWSQP VSFPSPQRRQ GLLVPRWQWS ASILVVVPIF LLLTGFVHLL FKLSPRLKRI
310 320 330 340 350 360
FYQNIPSPEA FFHPLYSVYH GDFQSWTGAR RAGPQARQNG VSTSSAGSES SIWEAVATLT
370 380 390 400 410 420
YSPACPVQFA CLKWEATAPG FPGLPGSEHV LPAGCLELEG QPSAYLPQED WAPLGSARPP
430 440 450 460
PPDSDSGSSD YCMLDCCEEC HLSAFPGHTE SPELTLAQPV ALPVSSRA